Search research articles
Contact Us
Filters
Showing results (191-200 of 289) with videos related to
Page
of 29
Sort By:
Contact Dermatitis
|
April 11, 2018
Prevalence of contact allergy to metals in the European general population with a focus on nickel and piercings: The EDEN Fragrance Study
Marie L A Schuttelaar, Robert F Ofenloch, Magnus Bruze, et al.
Dermatology (Basel, Switzerland)
|
September 24, 2008
Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project
Luigi Naldi, Antonio Addis, Sergio Chimenti, et al.
The Cochrane Database of Systematic Reviews
|
July 12, 2023
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Emilie Sbidian, Anna Chaimani, Robin Guelimi, et al.
The Cochrane Database of Systematic Reviews
|
May 23, 2022
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, et al.
JAAD International
|
August 19, 2021
Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
Arnon D Cohen, Ronald Vender, Luigi Naldi, et al.
Journal of the American Academy of Dermatology
|
January 14, 2015
WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Kim Papp, Alice B Gottlieb, Luigi Naldi, et al.
The Journal of Investigative Dermatology
|
September 7, 2007
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
Maja Mockenhaupt, Cecile Viboud, Ariane Dunant, et al.
The Journal of Allergy and Clinical Immunology
|
November 8, 2020
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
Paolo Gisondi, Stefano Piaserico, Luigi Naldi, et al.
Journal of Drugs in Dermatology : JDD
|
July 8, 2015
Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Kim Papp, Alice B Gottlieb, Luigi Naldi, et al.
Recenti Progressi in Medicina
|
October 2, 2025
Tiziana Pinciroli, Luigi De Angelis, Francesco Andrea Causio, et al.
Page
of 29
Search research articles
Search
Showing results (191-200 of 289) with videos related to
Sort By:
Page
of 29
Contact Dermatitis
|
April 11, 2018
Prevalence of contact allergy to metals in the European general population with a focus on nickel and piercings: The EDEN Fragrance Study
Marie L A Schuttelaar, Robert F Ofenloch, Magnus Bruze, et al.
Dermatology (Basel, Switzerland)
|
September 24, 2008
Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project
Luigi Naldi, Antonio Addis, Sergio Chimenti, et al.
The Cochrane Database of Systematic Reviews
|
July 12, 2023
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Emilie Sbidian, Anna Chaimani, Robin Guelimi, et al.
The Cochrane Database of Systematic Reviews
|
May 23, 2022
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, et al.
JAAD International
|
August 19, 2021
Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
Arnon D Cohen, Ronald Vender, Luigi Naldi, et al.
Journal of the American Academy of Dermatology
|
January 14, 2015
WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Kim Papp, Alice B Gottlieb, Luigi Naldi, et al.
The Journal of Investigative Dermatology
|
September 7, 2007
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
Maja Mockenhaupt, Cecile Viboud, Ariane Dunant, et al.
The Journal of Allergy and Clinical Immunology
|
November 8, 2020
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
Paolo Gisondi, Stefano Piaserico, Luigi Naldi, et al.
Journal of Drugs in Dermatology : JDD
|
July 8, 2015
Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Kim Papp, Alice B Gottlieb, Luigi Naldi, et al.
Recenti Progressi in Medicina
|
October 2, 2025
Tiziana Pinciroli, Luigi De Angelis, Francesco Andrea Causio, et al.
Page
of 29